López A F, Begley G, Andrews P, Butterworth A E, Vadas M A
J Immunol. 1985 Jun;134(6):3969-77.
A human neutrophil- and eosinophil-specific surface antigen, GFA-2, has been found to be involved in the antibody-dependent cell-mediated cytotoxicity (ADCC) to extracellular targets, and in phagocytosis. The monoclonal antibody (MAb) WEM-G11 was produced which recognizes the GFA-2 structure. This MAb, when used as F(ab')2, stimulated human neutrophils to kill antibody-coated P815 cells and, in the case of human eosinophils, increased their cytotoxic effect on schistosomula of Schistosoma mansoni in a dose-dependent manner. MAb WEM-G11 F(ab')2 also stimulated the phagocytosis of antibody-coated sheep erythrocytes by neutrophils. The effect of WEM-G11 F(ab')2 was specific, because other MAb, whether tested in the form of F(ab')2 fragments or as whole IgG, failed to stimulate neutrophils despite binding to these cells. In contrast to the F(ab')2 fragments of these cells. In contrast to the F(ab')2 fragments of WEM-G11, the whole IgG of this MAb inhibited ADCC and phagocytosis, presumably through interaction with granulocyte Fc receptors. WEM-G11 F(ab')2, and to a greater extent WEM-G11 IgG, induced degranulation, but only from cytochalasin B-treated neutrophils. GFA-2 was absent from lymphocytes, monocytes, erythrocytes, and myeloid and erythroid colony-forming cells, as shown by flow cytometry and colony-forming experiments. GFA-2 appeared at the promyelocytic stage and increased in density as neutrophils became more mature. In the mature neutrophil, the number of binding sites for WEM-G11 were found to be about 20,000 per cell. By immunoprecipitation, it appeared that GFA-2 consisted of a polypeptide chain of about 95,000 m.w. and a low m.w. peptide of about 43,000. By immunoblotting, it was demonstrated that the epitope recognized by WEM-G11 is in the chain of m.w. 95,000. GFA-2 thus constitutes a novel human granulocyte-specific antigen that is central to the functional activity and differentiation of these cells.
一种人类嗜中性粒细胞和嗜酸性粒细胞特异性表面抗原GFA - 2,已被发现参与针对细胞外靶标的抗体依赖性细胞介导的细胞毒性作用(ADCC)以及吞噬作用。产生了识别GFA - 2结构的单克隆抗体(MAb)WEM - G11。该单克隆抗体以F(ab')2形式使用时,可刺激人类嗜中性粒细胞杀伤抗体包被的P815细胞,对于人类嗜酸性粒细胞而言,则以剂量依赖性方式增强其对曼氏血吸虫童虫的细胞毒性作用。MAb WEM - G11 F(ab')2还可刺激嗜中性粒细胞对抗体包被的绵羊红细胞的吞噬作用。WEM - G11 F(ab')2的作用具有特异性,因为其他单克隆抗体,无论是以F(ab')2片段形式还是完整IgG形式进行检测,尽管能与这些细胞结合,但都无法刺激嗜中性粒细胞。与这些细胞的F(ab')2片段形成对比。与WEM - G11的F(ab')2片段相反,该单克隆抗体的完整IgG抑制ADCC和吞噬作用,推测是通过与粒细胞Fc受体相互作用实现的。WEM - G11 F(ab')2,以及在更大程度上WEM - G11 IgG,可诱导脱颗粒,但仅来自经细胞松弛素B处理的嗜中性粒细胞。流式细胞术和集落形成实验表明,淋巴细胞、单核细胞、红细胞以及髓系和红系集落形成细胞均不存在GFA - 2。GFA - 2出现在早幼粒细胞阶段,并随着嗜中性粒细胞的成熟而密度增加。在成熟的嗜中性粒细胞中,发现每个细胞上WEM - G11的结合位点数量约为20,000个。通过免疫沉淀法,似乎GFA - 2由一条分子量约为95,000的多肽链和一条分子量约为43,000的低分子量肽组成。通过免疫印迹法证明,WEM - G11识别的表位位于分子量为95,000的链中。因此,GFA - 2构成了一种新型的人类粒细胞特异性抗原,对这些细胞的功能活性和分化至关重要。